Morgan Stanley’s Pasithea Therapeutics KTTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,000	Closed	-$3.15K	–	8164
2024 Q4	$3.15K	Sell	1,000 -500	-33%	-$1.58K	﹤0.01%	7106
2024 Q3	$8.13K	Buy	+1,500	New	+$8.13K	﹤0.01%	6777